Harlan S. Robins, Chief Scientific Officer at Adaptive Biotechnologies Corp (ADPT), sold 193,312 shares at $6.99 ($1.4M) on 2025-03-05, disclosed to the SEC on 2025-03-06.
Seasonal sale ($1.4M) by Chief Scientific Officer — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.98 | 40,603 | $283K | 21.0% |
| 2 | $6.98 | 40,603 | $283K | 21.0% |
| 3 | $6.99 | 56,053 | $392K | 29.0% |
| 4 | $6.99 | 56,053 | $392K | 29.0% |
| Total | $6.99 avg | 193,312 | $1.4M | 100% |
| Filing → |
| ADPT | SELL | 2026-06-17 | $1.8M | — | Filing → |
| ADPT | SELL | 2026-04-10 | $149K | — | Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |